| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | VERTEX PHARMACEUTICALS INCOR | Jun 2, 2026 | |
| Buy | VERTEX PHARMACEUTICALS INC/C | Apr 30, 2026 | |
| Sell | VERTEX ANALYTICS, INC CMN | Apr 24, 2026 | |
| Buy | VERISK ANALYTICS, INC CMN | Apr 24, 2026 | |
| Buy | VERTEX ANALYTICS, INC CMN | Apr 20, 2026 | |
| Buy | VERTEX PHARMACEUTICALS INCOR | Apr 20, 2026 | |
| Sell | VERTEX ANALYTICS, INC CMN | Apr 2, 2026 | |
| Buy | VERISIGN ANALYTICS, INC CMN | Apr 2, 2026 | |
| Sell | MGMT INTRACITECHNOLOGY INC | Feb 24, 2026 | |
| Sell | VERTEX PHARMACEUTICALS INC C | Feb 5, 2026 |
This page tracks congressional stock trading activity in Vertex Pharmaceuticals Incorporated (VRTX) in the Healthcare sector. Disclosed Capitol has indexed 132 disclosed congressional trades involving VRTX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 132 disclosed congressional trades in Vertex Pharmaceuticals Incorporated (VRTX) — 67:36 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| 2026-06-02 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| 2026-04-30 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| 2026-04-24 | Ro Khanna | D | Sell | $15,001 - $50,000 |
| 2026-04-24 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| 2026-04-20 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| 2026-04-20 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| 2026-04-02 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| 2026-04-02 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| 2026-02-24 | Michael McCaul | R | Sell | $250,001 - $500,000 |
| 2026-02-05 | Ro Khanna | D | Sell | $1,001 - $15,000 |
Across the 132 disclosed congressional trades in Vertex Pharmaceuticals Incorporated (VRTX), members of Congress have reported 36 buys and 67 sells. The average 30-day alpha vs. the S&P 500 is 0.48%.